Table 2. Mount number, intromission number, increase in ICP and ICP/MAP and duration.
Group | MN | IN | Increase in ICP (mmHg) | MAP (mmHg) | ICP/MAP | Duration(s) |
NC | 8 | 5 | 65.78±12.84 # | 82.22±6.48 | 0.79±0.16 # | 65.6±5.9 # |
BIIAL | 3 | 0 | 19.24±7.74 * # | 83.60±7.46 | 0.23±0.09 * | 36.3±4.3 * # |
HFD | 6 | 3 | 24.84±10.22 * # | 87.80±5.88 | 0.30±0.12 * # | 48.8±7.5 * # |
BCH | 0 | 0 | 6.42±2.40 * | 85.24±6.52 | 0.07±0.03 * | 28.7±3.8 * |
MS | 7 | 5 | 58.96±9.66 # | 83.04±6.46 | 0.71±0.12 # | 70.4±6.8 # |
* p<0.05 vs. NC group;
# p<0.05 vs. BCH group.